ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: GluN2A; Glutamate [NMDA] receptor subunit epsilon-1; Glutamate receptor ionotropic NMDA 2A; N-methyl D-aspartate receptor subtype 2A; NR2A; hNR2A
Storage: 2-8C
Application: Western Blotting Analysis: A 1:2,000 dilution from a representative lot detected NMDAR2A in mouse brain tissue lysate.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected NMDAR2A in SH-SY5Y cells.Immunohistochemistry (Paraffin) Analysis: A 1:200 dilution from a representative lot detected NMDAR2A in rat brain tissue sections.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany